Anthem

The new joint venture will leverage AI technology to create digital healthcare solutions for the employer and consumer markets.  

Also: NIH moves forward with physIQ's COVID digital biomarkers; Tyto Care adds pulse oximeter.

Also: Withings’ remote monitoring system becomes widely available through Redox partnership. Renalytix AI and DaVita team up to offer early intervention for kidney disease.

This week's top stories include a Universal Health Services cyberattack, Anthem reaching a $39.5 million settlement in a 2015 attack, and Apple Watch's abnormal pulse feature driving unnecessary healthcare visits.

Efficient distribution, dissipating stigma and an emphasis on decentralized trials are all working in favor of digital treatments, according to a panel of digital therapeutics executives and industry stakeholders.

The 900-participant study uses learnings from Apple's Tueo Health acquisition and could inform the development of a digital biomarker for asthma.

The deal comes with an investment of "tens of millions of dollars" from Anthem to K Health.